ChemicalBook > CAS DataBase List > Carteolol hydrochloride

Carteolol hydrochloride

Product Name
Carteolol hydrochloride
CAS No.
51781-21-6
Chemical Name
Carteolol hydrochloride
Synonyms
endak;oc1085;Tenalet;Cartrol;Carteol;Teoptic;Cartelo;mikelan;opc1085;Cartelol
CBNumber
CB6335371
Molecular Formula
C16H25ClN2O3
Formula Weight
328.83
MOL File
51781-21-6.mol
More
Less

Carteolol hydrochloride Property

Melting point:
278°C
storage temp. 
Refrigerator
solubility 
Soluble in water, sparingly soluble in methanol, slightly soluble in ethanol 96 per cent, practically insoluble in methylene chloride.
form 
Solid
color 
White to Off-White
Merck 
14,1866
More
Less

Safety

RTECS 
VC8282000
HS Code 
2933790002
Toxicity
LD50 in male mice, rats (mg/kg): 810, 1380 orally; 54.5, 158 i.v.; 380, 400 i.p. (Lang)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
Y0000193
Product name
Carteolol for system suitability
Purity
European Pharmacopoeia (EP) Reference Standard
Packaging
y0000193
Price
$150
Updated
2024/03/01
Sigma-Aldrich
Product number
BP567
Product name
Carteolol hydrochloride
Purity
British Pharmacopoeia (BP) Reference Standard
Packaging
100MG
Price
$208
Updated
2024/03/01
Sigma-Aldrich
Product number
1096757
Product name
Carteolol for system suitability
Packaging
200mg
Price
$416
Updated
2024/03/01
Cayman Chemical
Product number
23758
Product name
Carteolol (hydrochloride)
Purity
≥98%
Packaging
25mg
Price
$68
Updated
2024/03/01
Cayman Chemical
Product number
23758
Product name
Carteolol (hydrochloride)
Purity
≥98%
Packaging
50mg
Price
$121
Updated
2024/03/01
More
Less

Carteolol hydrochloride Chemical Properties,Usage,Production

Chemical Properties

Crystalline Solid

Uses

β-Adrenergic blocker. Antihypertensive; antianginal; antiarrhythmic; antiglaucoma.

brand name

Cartrol (Abbott); Ocupress (Novartis).

Biological Activity

beta-adrenergic antagonist are an important class of drugs for the treatment of various heart diseases, such as high blood pressure, insufficiency of blood flow to the heart muscle, irregular heart beat, thickened heart muscle, and decreased ability of the heart to empty or fill normally. β-blockers can also be used to treat migraine headache and increased eye pressure (glaucoma). carteolol is a nonselective beta-adrenoceptor antagonist.

Pharmacology

Carteolol hydrochloride is a powerful beta-adrenergic receptor antagonist characterized by a long-term pharmacological action, the lack of beta receptor selectivity, an intrinsic sympathomimetic activity (ISA), and a slight local anaesthetic activity (approximately 1/10 of that of propranolol). This drug has a dose-dependent hypotensive effect and does not engender the onset of tachyphylaxis. The pharmacological action consists in the decreased formation of aqueous humor, probably by acting at the level of the ciliary body presenting a wealth of ?2 receptors. The intrinsic sympathomimetic activity of carteolol is responsible for the low incidence of side effects and, thus, for maintaining the heart rate, pulse rate, and arterial blood pressure within the normal physiological range.

Pharmacokinetics

The instillation of carteolol hydrochloride is followed by the rapid absorption by the ocular tissues. Following the instillation of 10μl of 14C-carteolol ophthalmic solution 20 mg/ml into rabbit eyes, the highest platelet and tissue concentrations were obtained between 30 minutes to 2 hours. The study shows that, following topical application, carteolol spreads rapidly into the ocular tissues, passing the corneal barrier. The highest concentrations of 14C-carteolol were found in the following ocular tissues: cornea, iris, anterior sclera, ciliary body conjunctiva, and extraocular muscle. Slightly lower concentrations were found in the retina, choroid, posterior sclera, optic nerve, and aqueous humor. The concentration was especially low in the lens, vitreous body, and plasma. In the various tissues of the contralateral eye, very low radioactivity levels were measured. After the instillation of one drop of carteolol ophthalmic solution 20 mg/ml in healthy volunteers, the plasma concentrations were negligible (1-2 ng/ml). Approximately 16% of the dose is excreted in the urine as an unchanged compound during the first 24 hours after the instillation of a single drop of carteolol hydrochloride 20 mg/ml. The urinary elimination half-life following topical application is about 5 hours.

Clinical Use

The chemical name for carteolol hydrochloride (carteolol) is (±)-5-[3-[(1,1-dimethyl ethyl) amino]-2-hydroxypropoxy]-3,4-dihydro-2(1H)-quinolinone monohydrochloride. Carteolol Hydrochloride (carteolol) Ophthalmic Solution USP, 1% is a nonselective beta-adrenoceptor blocking agent for ophthalmic use. Each mL of sterile solution contains Active: carteolol hydrochloride (carteolol) 10 mg (1%). This drug is used to treat open-angle glaucoma and other causes of high pressure inside the eye. Carteolol hydrochloride ophthalmic may interact with oral carteolol, digoxin, reserpine, insulin or oral diabetes medications, other beta-blockers, calcium channel blockers, or medicines to treat psychiatric disorders.

in vitro

previous findings demonstrate that carteolol, unlike xamoterol, is a nonconventional partial agonist, which causes agonistic effects via interaction with the low-affinity propranolol-resistant site of β1-adrenoceptors and antagonistic actions by the high-affinity site of the same receptors [1].

in vivo

both 8-oh carteolol and carteolol suppressed the water-load induced intraocular pressure (iop) rise in rabbits. 8-oh carteolol was more effective in suppressing water-load induced iop rise in rabbits compared with carteolol on equimolar basis. both 8-oh carteololand carteolol caused a significant decrease in iop in monkeys. 8-oh carteolol was estimated to be more potent than carteolol in lowering iop on equimolar basis in monkeys [2].

References

[1] maura floreani, guglielmina froldi, luigi quintieri, katia varani, pier andrea borea, maria teresa dorigo and paola dorigo. in vitro evidence that carteolol is a nonconventional partial agonist of guinea pig cardiac β1-adrenoceptors: a comparison with xamoterol. jpet 315:1386–1395, 2005
[2] sugiyama k, enya t, kitazawa y. ocular hypotensive effect of 8-hydroxycarteolol, a metabolite of carteolol. int ophthalmol. 1989 jan;13(1-2):85-9.
[3] trinquand c, romanet jp, nordmann jp, allaire c; groupe d'étude. efficacy and safety of long-acting carteolol 1% once daily. a double-masked, randomized study. j fr ophtalmol. 2003 feb;26(2):131-6.

Carteolol hydrochloride Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Carteolol hydrochloride Suppliers

Jinan Duowei Innovation Biotechnology Co., Ltd
Tel
0531-58595315 13864187945
Email
415834789@qq.com
Country
China
ProdList
93
Advantage
58
Jinan Hongwan Biotechnology Co., Ltd.
Tel
0531-58767175 13220585822
Email
1256200339@qq.com
Country
China
ProdList
35
Advantage
58
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
32321
Advantage
50
Sinopharm Chemical Reagent Co,Ltd.
Tel
86-21-63210123
Fax
86-21-63290778 86-21-63218885
Email
sj_scrc@sinopharm.com
Country
China
ProdList
9815
Advantage
79
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7552
Advantage
61
TOKYO CHEMICAL INDUSTRY CO., LTD.
Tel
03-36680489
Fax
03-3668-0520
Email
Sales-JP@TCIchemicals.com
Country
Japan
ProdList
28387
Advantage
80
TCI Europe
Tel
320-37350700
Fax
+32 (0)37350701
Email
sales@tcieurope.eu
Country
Europe
ProdList
23671
Advantage
75
TCI AMERICA
Tel
800-4238616
Fax
+1-888-520-1075 / +1-503-283-1987
Email
sales@tciamerica.com
Country
Americas
ProdList
23653
Advantage
75
Nanjing Sunlida Biological Technology Co., Ltd.
Tel
025-57798810
Fax
025-57019371
Email
sales@sunlidabio.com
Country
China
ProdList
3239
Advantage
55
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2782
Advantage
58
More
Less

View Lastest Price from Carteolol hydrochloride manufacturers

Zibo Hangyu Biotechnology Development Co., Ltd
Product
Carteolol hydrochloride 51781-21-6
Price
US $80.00-800.00/KG
Min. Order
1KG
Purity
0.99
Supply Ability
20 tons
Release date
2023-10-20
Zhuozhou Wenxi import and Export Co., Ltd
Product
Carteolol hydrochloride 51781-21-6
Price
US $15.00-10.00/KG
Min. Order
1KG
Purity
99%+ HPLC
Supply Ability
Monthly supply of 1 ton
Release date
2021-07-10
Zhuozhou Wenxi import and Export Co., Ltd
Product
Carteolol hydrochloride 51781-21-6
Price
US $15.00-10.00/KG
Min. Order
1KG
Purity
99%+ HPLC
Supply Ability
Monthly supply of 1 ton
Release date
2021-07-09

51781-21-6, Carteolol hydrochlorideRelated Search:


  • CARTEOLOL (HYDROCHLORIDE);NSC 300906;OPC 1085
  • 5-[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2(1H)-quinolinone Hydrochloride
  • 5-[3-[(tert-butyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2-quinolone monohydrochloride
  • Arteoptic
  • Caltidren
  • Carteol
  • Cartrol
  • dl-Carteolol hydrochloride
  • NSC 300906
  • Optipress
  • Tenalet
  • Teoptic
  • Cartelo
  • Cartelol
  • Carteolol T
  • Orukalol
  • Carteolol Hydrochloride (200 mg)
  • Ocupress
  • 2(1H)-Quinolinone,5-[3-[(1,1-diMethylethyl)aMino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride(1:1)
  • 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2(1H)-quinolinone,hydrochloride (1:1)
  • Carteolol monohydrochloride
  • 5-(2-hydroxy-3-tert-butylamino)propoxy-3,4-dihydrocarbostyrilhydrochloride
  • 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-2(1h)-quinolin
  • 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyrilhydrochloride
  • 5-(3-tert-butylamino-2-hydroxy-propoxy)-3,4-dihydro-2(1h)-chinolinon-hydroch
  • abbott-43326
  • carbonolol
  • carteololhydrochloride
  • endak
  • endakmite
  • mikelan
  • oc1085
  • opc1085
  • 2(1H)-QUINOLINONE, 5-[3-[(1,1-DIMETHYLETHYL)AMINO]-2-HYDROXYPROPOXY]-3,4-DIHYDRO-, MONOHYDROCHLORIDE
  • carteolol HCl
  • Carteolol for system suitability CRS
  • OPC-1085 hydrochloride
  • 5-[(2RS)-3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]- 3,4-dihydroquinolin-2(1H)-one hydrochloride
  • Carteolol hydrochloride USP/EP/BP
  • Carteolol HCl (OPC-1085 HCl)
  • 2(1H)-QUINOLINONE, 5-[3-[(1,1-DIMETHYLETHYL)AMINO]-2-HYDROXYPROPOXY]-3,4-DIHYDRO-, MONOHYDROCHLORIDE 51781-21-6
  • Carteolol Hydrochloride (1096757)
  • Carteolol Hydrochloride CAS NO.51781-21-6
  • 51781-21-6
  • C16H25ClN2O3
  • C16H24N2O3HCl
  • 32883
  • API
  • CARTROL
  • Intermediates & Fine Chemicals
  • Pharmaceuticals